Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Ghobrial
R M
RM
Department of Surgery, School of Medicine, University of California at Los Angeles 90095, USA.
Colquhoun
S
S
Rosen
H
H
Hollis
P
P
Ponthieux
S
S
Pakrasi
A
A
Farmer
D G
DG
Markman
J F
JF
Markowitz
J
J
Drazan
K
K
Yersiz
H
H
Singer
J
J
Stribling
R
R
Arnout
W
W
Holt
C D
CD
Goss
J
J
Imagawa
D
D
Seu
P
P
Goldstein
L I
LI
Shackleton
C R
CR
Martin
P
P
Busuttil
R W
RW
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000503:physiopathology* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012086:Reoperation; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D016559:Tacrolimus